ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
Cash flow statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.5B | $19.0B | $18.8B | $22.8B | $24.9B | $22.8B | $17.6B | $13.3B | $13.4B | $10.0B | $7.0B | $7.5B | $3.5B | $6.3B | $6.3B | $6.2B |
| Capital expenditures | $1.3B | $1.2B | $974M | $777M | $695M | $787M | $798M | $552M | $638M | $529M | $479M | $532M | $612M | $491M | $333M | $356M |
| Free cash flow | $18.2B | $17.8B | $17.8B | $22.1B | $24.2B | $22.0B | $16.8B | $12.8B | $12.8B | $9.4B | $6.6B | $7.0B | $2.9B | $5.8B | $6.0B | $5.9B |
| Stock-based compensation | $976M | $955M | $911M | $747M | $671M | $692M | $753M | $430M | $421M | $365M | $353M | $282M | $241M | $212M | $187M | $163M |
| Buybacks | $1.5B | $980M | $1.7B | $2.0B | $1.5B | $934M | $978M | $629M | $12.0B | $1.4B | $6.0B | $7.6B | $665M | $320M | — | — |
| Dividends paid | $12.0B | $11.7B | $11.0B | $10.5B | $10.0B | $9.3B | $7.7B | $6.4B | $5.6B | $4.1B | $3.7B | $3.3B | $2.7B | $2.6B | — | — |
| Dividends per share | $6.83 | $6.65 | $6.29 | $5.99 | $5.71 | $5.31 | $4.84 | $4.39 | $3.95 | $2.63 | $2.35 | $2.10 | $1.75 | $2.00 | — | — |
| Free cash flow margin | 28.3% | 29.1% | 31.7% | 40.6% | 41.8% | 39.1% | 36.7% | 38.4% | 39.0% | 33.4% | 25.6% | 30.6% | 14.7% | 30.7% | 32.7% | 33.8% |